Zyesami FDA Approval Status
FDA Approved: No
Brand name: Zyesami
Generic name: aviptadil
Company: NRx Pharmaceuticals
Treatment for: COVID-19
Zyesami (aviptadil) is an inhaled formulation of synthetic human Vasoactive Intestinal Polypeptide (VIP) in development for the treatment of patients with critical COVID-19 respiratory failure.
Development timeline for Zyesami
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.